Why Is Mukka Proteins Share Price Falling Key Reasons 2026

Mukka Proteins share price is down 17% from Rs 29 to Rs 24 in 2026. FII selling, earnings pressure and valuation de-rating in the Fishmeal and Fish Oil Processing sector drive the decline.

The Mukka Proteins share price falling trend has become a key investor concern in 2026. With Mukka Proteins share price falling approximately 17 percent from its 52 week high of Rs 29 to current levels near Rs 24, investors are asking whether this correction represents a buying opportunity or signals deeper structural challenges. Mukka Proteins (NSE: MUKKA), listed in the Fishmeal and Fish Oil Processing space, has witnessed sustained selling pressure through FY26. Understanding the Mukka Proteins share price falling narrative requires careful analysis of both company-specific headwinds and the broader macro forces at work in 2026.

Click Here Get Free Investment Predictions

About Mukka Proteins

Manufacturer of fishmeal and fish oil from marine catch. Products used in aquaculture, poultry and pet food industries. Revenue Rs 400 crore. Circuit range Rs 19 to Rs 29. CMP Rs 24, down 17 percent. The stock is trading at approximately Rs 24, down approximately 17 percent from its 52 week high of Rs 29. The 52 week low stands at Rs 19. The Mukka Proteins share price falling trend reflects both sector headwinds and company-specific pressures that investors need to evaluate carefully.

Why Is Mukka Proteins Share Price Falling: Key Reasons

Use the Univest Screener to check live fundamentals of Mukka Proteins and compare with peers.

1. FII Selling and Broad Market Correction

The dominant external driver behind the Mukka Proteins share price falling is the sustained FII selling wave that swept Indian equities through FY26. The US reciprocal tariff announcement imposing a 26 percent levy on Indian goods triggered a broad risk-off selloff that saw FIIs pull significant capital from Indian equity markets. Mukka Proteins fell alongside the broader correction. The Mukka Proteins share price falling by 17 percent from its peak reflects the combination of macro-level FII selling and company-specific headwinds operating simultaneously in 2026.

2. Sector-Specific Headwinds in Fishmeal and Fish Oil Processing

Beyond the broad market decline, the Fishmeal and Fish Oil Processing sector has faced its own challenges in FY26. Analyst earnings estimates for the Fishmeal and Fish Oil Processing space have been revised downward as input costs, competitive pricing pressures and demand moderation weighed on sector outlook. When sector-level earnings expectations decline simultaneously, institutional investors reduce overall sector exposure, leading to uniform price declines across the peer group. The Mukka Proteins share price falling trend is in part a function of this broader sector de-rating that continued through 2026.

3. Earnings Growth Deceleration and Margin Compression

A significant company-specific driver behind the Mukka Proteins share price falling is the deceleration in earnings growth relative to the elevated expectations priced in at its 52 week high of Rs 29. Revenue and profitability have come under pressure from input cost inflation, competitive pricing constraints and higher operating expenditure. The market is now recalibrating to a more moderate earnings trajectory, which has become a core driver of the Mukka Proteins share price falling below prior analyst targets.

4. Valuation De-Rating from Peak Multiples

At its 52 week high of Rs 29, Mukka Proteins was trading at valuation multiples above its historical average. As actual results came in below peak expectations and sector sentiment turned cautious, the market applied lower multiples to Mukka Proteins earnings. This valuation de-rating from Rs 29 to the current Rs 24 explains a significant portion of the 17 percent decline in the Mukka Proteins share price falling phase.

5. Small and Mid Cap Liquidity Squeeze

With a market capitalisation of approximately Rs 600 crore, Mukka Proteins is exposed to the liquidity dynamics of the small and mid cap segment, which experienced a sharp liquidity squeeze in FY25-26. When domestic mutual funds face redemption pressure and retail investors turn risk-averse, smaller companies bear disproportionate selling pressure, amplifying the Mukka Proteins share price falling trend beyond what fundamentals would suggest.

6. Global Macroeconomic Uncertainty

India’s equity market in FY26 faced an unusually concentrated set of macro headwinds including global tariff wars, crude oil price volatility, currency pressure and concerns about the pace of domestic earnings recovery. The Mukka Proteins share price falling trend has been reinforced by this macro overhang that keeps institutional buyers cautious even when individual company fundamentals do not fully justify the magnitude of the decline.

Financial Performance Analysis of Mukka Proteins

The key financial metrics driving the Mukka Proteins share price falling narrative are visible in both recent quarterly trends and valuation de-rating. The stock has fallen 17 percent from its 52 week high of Rs 29 to the current Rs 24. The market cap has contracted to approximately Rs 600 crore. Investors tracking the Mukka Proteins share price falling should monitor the upcoming results and management commentary on margin and revenue recovery.

Technical Signals What the Charts Are Saying

On the technical charts, the Mukka Proteins share price falling pattern is confirmed by the stock trading below its 50 day, 100 day, and 200 day simple moving averages, all of which are sloping downward. Since its 52 week high of Rs 29, Mukka Proteins has formed a pattern of lower highs and lower lows. Key support for the Mukka Proteins share price falling trend is at the 52 week low of Rs 19. Overhead resistance is at the Rs 29 zone where investors who bought near the peak create selling pressure on recovery attempts. Download the Univest iOS App or Univest Android App to track Mukka Proteins live price and get daily expert stock picks.

Can Mukka Proteins Share Price Recover

Despite the headwinds currently driving the Mukka Proteins share price falling, genuine recovery catalysts exist for long-term investors. First, any positive inflection in the Fishmeal and Fish Oil Processing sector driven by improved macro conditions or policy support could trigger a sharp re-rating for Mukka Proteins. Second, a quarterly earnings result that beats the now-reduced analyst expectations could catalyse a short-covering rally from oversold levels. Third, a broad recovery in Indian small and mid cap market sentiment as FII flows normalise would lift Mukka Proteins along with the broader peer group.

The contrarian view is that at Rs 24, a significant portion of the bad news driving the Mukka Proteins share price falling is already priced in. The stock is down 17 percent from its peak and the valuation has compressed meaningfully, creating a potentially attractive entry point for patient investors with a 2 to 3 year horizon.

Conclusion

The Mukka Proteins share price falling by approximately 17 percent from its 52 week high of Rs 29 to the current Rs 24 reflects broad market headwinds, FII selling, earnings deceleration and valuation de-rating in the Fishmeal and Fish Oil Processing sector. The Mukka Proteins share price falling trend will require a clear reversal in quarterly financial momentum and improved macro sentiment to arrest sustainably. Investors monitoring the Mukka Proteins share price falling should closely watch upcoming results, management commentary on growth and margin recovery, and shifts in FII ownership. For real-time tracking, visit Univest.

Disclaimer Note: Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Data sourced from publicly available open sources. SEBI Registration No. INH000013776.

Frequently Asked Questions

Why is Mukka Proteins share price falling in 2026?

Ans. The Mukka Proteins share price falling in 2026 is driven by FII selling triggered by the US tariff announcement, sector headwinds in the Fishmeal and Fish Oil Processing space, earnings deceleration, and valuation de-rating from peak multiples. The decline is approximately 17% from the 52 week high of Rs 29 to Rs 24.

What is the 52 week high and low of Mukka Proteins?

Ans. The 52 week high of Mukka Proteins is Rs 29 and the 52 week low is Rs 19. The current price of approximately Rs 24 represents a decline of about 17% from the 52 week high.

Should I buy Mukka Proteins shares at current levels?

Ans. Whether to buy Mukka Proteins at Rs 24 depends on your investment horizon and risk appetite. The stock has fallen 17% from its peak, which may improve the risk-reward for long-term investors. Always consult a SEBI registered financial advisor before any investment decision.

What are the recovery triggers for Mukka Proteins?

Ans. Key recovery catalysts for Mukka Proteins include quarterly earnings beating reduced analyst expectations, reversal of FII selling as global macro improves, positive sector re-rating in the Fishmeal and Fish Oil Processing space, and a broader Indian mid and small cap market recovery.

What are the key downside risks to Mukka Proteins stock?

Ans. Key risks include continued earnings estimate downgrades, further FII selling, unexpected regulatory or competitive developments in the Fishmeal and Fish Oil Processing sector, and a deeper correction in the broader Indian equity market testing the 52 week low of Rs 19.

What is the market cap of Mukka Proteins?

Ans. The current market capitalisation of Mukka Proteins is approximately Rs 600 crore based on the CMP of Rs 24. The market cap has compressed from its peak as the Mukka Proteins share price falling trend has persisted through 2026.